Andlauer Healthcare Group Inc.
AND.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 113.19M | 115.73M | 120.22M | 117.02M | 117.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 113.19M | 115.73M | 120.22M | 117.02M | 117.98M |
| Cost of Revenue | 74.31M | 77.62M | 79.42M | 76.98M | 78.51M |
| Gross Profit | 38.88M | 38.10M | 40.81M | 40.03M | 39.48M |
| SG&A Expenses | 12.23M | 10.58M | 9.12M | 9.84M | 10.41M |
| Depreciation & Amortization | 13.01M | 12.50M | 12.59M | 12.74M | 12.86M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 99.54M | 100.70M | 101.12M | 99.56M | 101.78M |
| Operating Income | 13.64M | 15.03M | 19.10M | 17.45M | 16.21M |
| Income Before Tax | 13.30M | 17.73M | 17.22M | 16.32M | 15.69M |
| Income Tax Expenses | 3.58M | 3.64M | 4.69M | 4.38M | 4.20M |
| Earnings from Continuing Operations | 9.72M | 14.09M | 12.52M | 11.94M | 11.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.72M | 14.09M | 12.52M | 11.94M | 11.50M |
| EBIT | 13.64M | 15.03M | 19.10M | 17.45M | 16.21M |
| EBITDA | 17.86M | 19.18M | 25.46M | 29.82M | 29.07M |
| EPS Basic | 0.25 | 0.36 | 0.32 | 0.30 | 0.28 |
| Normalized Basic EPS | 0.21 | 0.23 | 0.27 | 0.26 | 0.24 |
| EPS Diluted | 0.25 | 0.36 | 0.32 | 0.30 | 0.28 |
| Normalized Diluted EPS | 0.21 | 0.22 | 0.27 | 0.26 | 0.23 |
| Average Basic Shares Outstanding | 39.15M | 39.24M | 39.24M | 39.39M | 41.11M |
| Average Diluted Shares Outstanding | 39.81M | 39.85M | 39.75M | 39.96M | 41.76M |
| Dividend Per Share | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 |
| Payout Ratio | 34.93% | 23.25% | 24.63% | 26.54% | 25.12% |